Neurizon Therapeutics Limited (“Neurizon”), a clinical-stage biotech company dedicated to advancing treatments for ...

Special Report: Ahead of near-term readouts from a trial investigating NUZ-001’s effect in a mouse model of Parkinson’s, ...

Neurizon Therapeutics (ASX:NUZ) has confirmed its lead drug candidate has neuroprotective potential in an independent study. The study’s authors noted that NUZ-001’s cell survival effect was ...

Neurizon Therapeutics (ASX:NUZ) announces findings from an independent study conducted in collaboration with The University of Queensland. The study, presented at the AD/PD 2025 conference in Vienna, ...

Maiden drilling is now underway at the Rae project in Nunavut, Canada, following the mobilisation of drilling crews and White Cliff personnel to site. Initial drillholes have already returned ...

TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United ...

Maiden drilling is now underway at the Rae project in Nunavut, Canada, following the mobilisation of drilling crews and White Cliff personnel to site. Special report: Drilling operations have ...

A digital therapeutic (DTx) is defined as “health software intended to treat or alleviate a disease, disorder, condition, or injury by generating and delivering a medical intervention that has a ...